Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indian pharmaceuticals market had total revenues of $21.4bn in 2020, representing a compound annual growth rate (CAGR) of 6.8% between 2016 and 2020.
- A number of government initiatives are helping to support growth in the Indian pharmaceutical market, including the Production-Linked Incentive Scheme and the Promotion of Bulk Drug Parks scheme.
- India is ranked third globally for drug production by volume and is also the largest provider of generic drugs in the world.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the India pharmaceuticals market by value in 2020?
- What will be the size of the India pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in India's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. What impact is the COVID-19 pandemic having on the market?
8 Company Profiles
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Dr. Reddy's Laboratories Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: India pharmaceuticals market value: $ billion, 2016-20
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: India pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: India pharmaceuticals market share: % share, by value, 2020
Table 5: Sun Pharmaceutical Industries Ltd: key facts
Table 6: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 7: Sun Pharmaceutical Industries Ltd: Key Employees
Table 8: Lupin Ltd: key facts
Table 9: Lupin Ltd: Annual Financial Ratios
Table 10: Lupin Ltd: Key Employees
Table 11: Lupin Ltd: Key Employees Continued
Table 12: Aurobindo Pharma Ltd: key facts
Table 13: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 14: Aurobindo Pharma Ltd: Key Employees
Table 15: Dr. Reddy's Laboratories Limited: key facts
Table 16: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 17: Dr. Reddy's Laboratories Limited: Key Employees
Table 18: India size of population (million), 2016-20
Table 19: India gdp (constant 2005 prices, $ billion), 2016-20
Table 20: India gdp (current prices, $ billion), 2016-20
Table 21: India inflation, 2016-20
Table 22: India consumer price index (absolute), 2016-20
Table 23: India exchange rate, 2016-20
List of Figures
Figure 1: India pharmaceuticals market value: $ billion, 2016-20
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: India pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in India, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in India, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in India, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in India, 2020
Figure 10: India pharmaceuticals market share: % share, by value, 2020
